December 24, 2025 05:02 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Delhi erupts over lynching of Hindu man in Bangladesh; protest outside High Commission | Targeted killing sparks global outrage: American lawmakers condemn mob lynching of Hindu man in Bangladesh | Assam on a ‘powder keg’: Himanta Biswa Sarma flags demographic shift, Chicken’s Neck fears | Bangladesh on edge: Student leader shot as pre-poll violence deepens after Hadi killing | Historic deal sealed: India, New Zealand sign landmark Free Trade Agreement in record time | Supreme court snubs urgent plea to stop PMO’s chadar offering at Ajmer Sharif | Emergency landing drama: Air India flight heads back to Delhi after engine malfunction! | PM Modi slams ‘cut and commission’ TMC in virtual Taherpur address | US launches Operation Hawkeye Strike in Syria targeting ISIS after Americans killed | Horror on tracks: Rajdhani Express ploughs into elephant herd, eight killed in Assam
India UK

India, UK join forces on new £8 million scientific research

| @indiablooms | Jul 28, 2020, at 05:40 am

New Delhi/IBNS: Britain and India are deepening their existing scientific research collaboration with five new projects to tackle anti-microbial resistance (AMR) that could lead to important advances in the global fight against antibiotic-resistant bacteria and genes.

The funding awards were announced by Lord (Tariq) Ahmad of Wimbledon, Minister of State for South Asia and the Commonwealth, ahead of a virtual visit to India on 28 July.

India is a major producer of antimicrobials in the pharmaceutical industry global supply chain, and the research projects aim to develop a better understanding of how waste from antimicrobial manufacturing could be inadvertently fuelling AMR.

Subject to clearances, the five projects are planned for September 2020. The UK is contributing £4 million from the UK Research and Innovation Fund for International Collaboration, and India is matching this with its own resources (£8m in total).

Lord (Tariq) Ahmad said: “The UK has already partnered with India’s Serum Institute to manufacture the vaccine for Covid-19, if clinical trials are successful, with plans to distribute to a billion people across the developing world. But there is more we can do together to tackle urgent global health issues in the world. Our thriving research and innovation partnerships will benefit people in the UK and India, and beyond.”

Philip Barton, High Commissioner to India, said: “The UK is India’s second biggest research partner, with joint research expected to be worth £400 million by next year. This huge investment enables us to work closely together on global health challenges such as the search for a Covid-19 vaccine. Today’s announcement is another demonstration of our excellent research relationship and will strengthen the important fight against anti-microbial resistance.”

During the visit to India, Minister Lord (Tariq) Ahmad will chair a virtual roundtable with senior Indian and UK-based stakeholders on cold-chain technologies that are critical for the effective transport of vaccines, ensuring they successfully reach their final destination.

Other elements of the Minister’s visit include meeting with Indian Minister of State for External Affairs and Parliamentary Affairs, Minister Muraleedharan, to discuss a number of subjects including multilateral cooperation, a meeting with Gujarati Chief Minister Vijay Rupani, discussions with regional governments and others on opportunities in wind power and a virtual tour of a UK funded solar plant in Rajasthan.

(Image: Pixabay)


 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.